Update in Development: Section B—Autism Spectrum Disorder

Chapter

Abstract

The purpose of this update is to provide a review of current literature pertaining to Autism Spectrum Disorders and some of the more useful and practical innovations in the field, based on recent publications as well as some consensus. We have also taken the liberty of inserting some practical key points in the update. These are intended to facilitate acquisition of salient historical points, as well as demystifying the presentation of the diagnosis to parents and caregivers.

We will begin by giving a general overview of issues around prevalence and some discussion around etiology, assessment and treatment, and then select a few important and possibly controversial topics to discuss. Throughout the chapter, we will attempt to make things easy to understand, practical and as much as possible, evidence-based.

Keywords

Autism spectrum disorder Microarray Epigenetic Gender dysphoria/gender identification disorder Attention deficit hyperactivity disorder Anxiety Developmental coordination disorder Dysbiosis Irritability/aggression Intellectual disability Applied behavioral analysis 

References

  1. Agudelo A, Rosas-Bermudez A, et al. Birth spacing and risk of autism and other neurodevelopmental disabilities: a systematic review. Pediatrics. 2016;137(5):1–13.Google Scholar
  2. American Speech-Language Hearing AssociationAutism review; 2015. http://www.asha.org/PRPSpecificTopic.aspx?folderid=8589935303&section=Overview
  3. Anagnostou A, Zwaigenbaum L, et al. Autism spectrum disorder: advances in evidence-based practice. CMAJ. 2014;186(7):509–19.PubMedPubMedCentralGoogle Scholar
  4. Antshel MA, Zhang-James Y, et al. An update on the comorbidity of ADHD and ASD: a focus on clinical management. Expert Rev Neurother. 2013;16(3):279–93.Google Scholar
  5. Babenko O, Kovalchuk I, et al. stress-induced perinatal and transgenerational epigenetic programming of brain development and mental health. Neurosci Biobehav Rev. 2015;48:70–91.PubMedGoogle Scholar
  6. Bauman ML. Medical comorbidities in autism: challenges to diagnosis and treatment. Neurotherapeutics. 2010;7(3):320–7.PubMedPubMedCentralGoogle Scholar
  7. Beversdorf DQ, Manning SE, et al. Timing of prenatal stressors and autism. J Autism Dev Disord. 2005;35(4):471–8.PubMedGoogle Scholar
  8. Buie T, Campbell DB, et al. Evaluation, diagnosis and treatment of gastrointestinal disorders in individuals with autism spectrum disorders: a consensus report. Pediatrics. 2010;125(1):S1–18.PubMedGoogle Scholar
  9. Buio J. Prevalence of autism spectrum disorders, among children aged eight years: autism and developmental disabilities monitoring network. CDC. 2014;63(SS02):1–12.Google Scholar
  10. Burd L, Li Q, et al. Tourette syndrome and co-morbid pervasive developmental disorder. J Child Neurol. 2009;24(2):170–5.PubMedGoogle Scholar
  11. Buss C, Davis EP, et al. High pregnancy anxiety during mid-gestation is associated with decreased gray matter density 6–8 year-old children. Psychoneuroendocrinology. 2010;35(1):141–53.PubMedPubMedCentralGoogle Scholar
  12. Centres for Disease Control and Prevention 2016. http://www.cdc.gov/measles/cases-outbreaks.html.
  13. Cohen S, Conduit R, et al. The relationship between sleep and behaviour in autism spectrum disorders: a review. J Neurodev Disord. 2014;6(1):44.PubMedPubMedCentralGoogle Scholar
  14. Constantino J. 2012. Social responsiveness scale, second edition (SRS-2). www.wpspublish.com
  15. Cortesi F, Giannotti F, et al. Sleep in children with autism spectrum disorder. Sleep Med. 2010;11(7):659–64.PubMedGoogle Scholar
  16. Courchesne E, Carper R, et al. Evidence of brain overgrowth in the first year of life and autism. JAMA. 2003;290(3):337–44.PubMedGoogle Scholar
  17. Coury D. Medical treatment of autism spectrum disorders. Curr Opin Neurol. 2010;23:131–6.PubMedGoogle Scholar
  18. Coury DL, Ashwood P, et al. Gastrointestinal conditions in children with autism spectrum disorders: developing a research agenda. Pediatrics. 2012;130(2):S160–8.PubMedGoogle Scholar
  19. Craig F, Margari F, et al. A review of executive function deficits in autism spectrum disorder and attention deficit hyperactivity disorder. Neuropsychiatr Dis Treat. 2016;12:1191–202.PubMedPubMedCentralGoogle Scholar
  20. Crawford S. On the origins of autism: the quantitative threshold exposure hypothesis. Med Hypotheses. 2015;85:798–806.PubMedGoogle Scholar
  21. Davis NO, Kollins SH. Treatment of co-occurring attention deficit hyperactivity disorder and autism spectrum disorder. Neurotherapeutics. 2012;9:518–30.PubMedPubMedCentralGoogle Scholar
  22. Dawson G, Burner K. Behavioural interventions in children and adolescents with autism spectrum disorders: a review of recent findings. Curr Opin Pediatr. 2011;23(6):616–20.PubMedGoogle Scholar
  23. Dawson G, Rogers S, et al. Randomized controlled trial of an intervention for toddlers with autism: the early start Denver model. Pediatrics. 2010;125(1):e17–23.PubMedGoogle Scholar
  24. De Angelis M, Francavilla R, et al. Autism spectrum disorders and intestinal microbiota. Gut Microbes. 2015;6(3):207–13.PubMedPubMedCentralGoogle Scholar
  25. Demicheli V, Rivetti A, et al. Vaccines for measles mumps and rubella in children. Cochrane Database Syst Rev. 2012;2:CD004407.Google Scholar
  26. Doja A, Roberts W. Immunize stations in autism: a review of the literature. Can J Neurol Sci. 2006;33(4):341–6.PubMedGoogle Scholar
  27. Dosman CF, Brian JA, et al. Children with autism: effect of iron supplementation on sleep and ferritin. Pediatr Neurol. 2007;36(3):152–8.PubMedGoogle Scholar
  28. Dziuk MA, Gidley L, et al. Dyspraxia in autism associated with motor, social and communicative deficits. Dev Med Child Neurol. 2007;49(10):734–9.PubMedGoogle Scholar
  29. Evrard SG. Prenatal alcohol exposure as an etiological factor in neuropsychiatric diseases of childhood adolescence and adults. Vertex. 2010;21(92):260–5.PubMedGoogle Scholar
  30. Filipek PA, Accardo PJ, et al. Practice parameter: screening and diagnosis of autism. Neurology. 2000;55(4):468–79.PubMedGoogle Scholar
  31. Folstein SE, Carcache LM. Psychiatric comorbidity in autism spectrum disorder. In: CJ MD, editor. Autism spectrum disorder. Oxford University Press: Oxford; 2016.Google Scholar
  32. Fombonne E. Epidemiological trends in rates of autism. Mol Psychiatry. 2002;7(Suppl 2):S4–6.PubMedGoogle Scholar
  33. Fombonne E. Epidemiological surveys of autism and other pervasive developmental disorders: an update. J Autism Dev Disord. 2003a;33(3):365–82.PubMedGoogle Scholar
  34. Fombonne E. The prevalence of autism. JAMA. 2003b;289(1):87–9.PubMedGoogle Scholar
  35. Fombonne E. Epidemiology of autistic disorder and other pervasive developmental disorders. J Clin Psychiatry. 2005;66(suppl 10):3–8.PubMedGoogle Scholar
  36. Frye RE, Rossignol DA. Identification and treatment of pathophysiological comorbidities of autism spectrum disorders to achieve optimal outcomes. Clin Med Insights Pediatr. 2016;10:43–56.PubMedPubMedCentralGoogle Scholar
  37. Fung LK, Mahajan R, et al. Pharmacological treatment of severe irritability and problem behaviours in autism: a systematic review and meta-analysis. Pediatrics. 2016;137(2):S124–35.PubMedGoogle Scholar
  38. Goldman SE, Adkins KW, et al. Melatonin in children with autism spectrum disorders: endogenous and pharmacokinetic profiles in relation to sleep. J Autism Dev Disord. 2014;44(10):2525–35.PubMedPubMedCentralGoogle Scholar
  39. Groer MW, Gregory KE, et al. The very low birth weight infant microbiome and child health. Birth Defects Res C Embryo Today. 2015;105(4):252–64.PubMedGoogle Scholar
  40. Grossi E, Veggo F, et al. Pregnancy risk factors in autism: a pilot study with artificial neural networks. Pediatr Res. 2016;79(2):339–47.PubMedGoogle Scholar
  41. Hollander E, Chaplin W, et al. Divalproex sodium vs placebo for the treatment of irritability in children and adolescents with autism spectrum disorders. Neuropsychopharmacology. 2010;35(4):990–8.PubMedGoogle Scholar
  42. Huisman-van Dijk HM, van de Schoot R, et al. The relationship between tics, OC, ADHD and autism symptoms: a cross-disorder symptom analysis in Gilles de la Tourette syndrome patients and family-members. Psychiatry Res. 2016;237(2016):138–46.PubMedPubMedCentralGoogle Scholar
  43. Jain A, Marshall J, et al. Autism occurrence by MMR vaccine status among US children with older siblings with and without autism. Lancet. 2015;313(15):1534–40.Google Scholar
  44. Ji N, Finding RL. An update of pharmacotherapy for autism spectrum disorder in children and adolescents. Curr Opin Psychiatry. 2015;28:91–101.PubMedGoogle Scholar
  45. Joseph L, Soorya L, Thurm A. Autism spectrum disorder. Cambridge, MA: Hogrefe and Huber Publishers; 2014.Google Scholar
  46. Kalyva E, Kyriazi M, et al. A review of co-occurrence of autism spectrum disorder and Tourette syndrome. Res Autism Spectr Disord. 2016;24:39–51.Google Scholar
  47. Kasari C, Gulsrud AC, et al. Randomized controlled caregiver mediated joint engagement intervention for toddlers with autism. J Autism Dev Disord. 2010;40(9):1045–56.PubMedPubMedCentralGoogle Scholar
  48. King S, Dancause K, et al. Using natural disasters to study the effects of prenatal maternal stress on child health and development. Birth Defects Res C Embryo Today. 2012;96(4):273–88.PubMedGoogle Scholar
  49. Kinney DK, Miller AM, et al. Autism prevalence following prenatal exposure to hurricanes and tropical storms in Louisiana. J Autism Dev Disord. 2008;38(3):481–8.PubMedGoogle Scholar
  50. Kullage KM, Smaldone AM, Cohn EG. How will DSM 5 affect autism diagnosis? A systematic literature review and meta-analysis. J Autism Dev Disord. 2014;44(8):1918–32.Google Scholar
  51. Lecavalier L. Behavioural and emotional problems in young people with pervasive developmental disorders: relative prevalence, effects of subject characteristics and empirical classification. J Autism Dev Disord. 2006;36(8):1101–14.PubMedGoogle Scholar
  52. Lord C, Bishop SL. Recent advances in autism research as reflected in DSM-V criteria for autism spectrum disorder. Annu Rev Clin Psychol. 2015;11:53–70.PubMedGoogle Scholar
  53. Lord C, Rutter M. 2012. Autism diagnostic observation schedule, second edition (AD0S-2). www.wpspublish.com
  54. Lord C, Rutter M, et al. Autism diagnostic interview revised: a revised version of a diagnostic interview for caregivers of individuals with possible pervasive developmental disorders. J Autism Dev Disord. 1994;24(5):659–85.PubMedGoogle Scholar
  55. Lord C, Risi S, et al. Autism from 2 To 9 years of age. Arch Gen Psychiatry. 2006;63(6):694–701.PubMedGoogle Scholar
  56. Ludvigsson JF, et al. The nationwide study of the association between celiac disease and the risk of autism spectrum disorders. JAMA Psychiat. 2013;70(14):1224–30.Google Scholar
  57. Madsen KM, Hviid A, et al. A population-based study of measles, mumps, and rubella vaccination and autism. N Engl J Med. 2002;347(19):1477–82.PubMedGoogle Scholar
  58. Mahajan R, Bernal MP, et al. Clinical practice pathways for evaluation and medication choice for attention deficit/hyperactivity disorder symptoms in autism spectrum disorders. Pediatrics. 2012;m130(2):S125–38.Google Scholar
  59. Mannion A, Leader G. Gastrointestinal symptoms in autism spectrum disorder: a literature review. Rev J Autism Dev Disord. 2014;1:11–7.Google Scholar
  60. Marlow BW, Marzec ML, et al. Characterizing sleep in children with autism spectrum disorders: a multidimensional approach. Sleep. 2006;29(12):1563–71.Google Scholar
  61. Matelski L, Van de Water J. Risk factors in autism: thinking outside the brain. J Autoimmun. 2016;67:1–7.PubMedGoogle Scholar
  62. Mayer EA, Tillisch K, et al. Gut/brain axis and they microbiota. J Clin Invest. 2015;125(3):926–38.PubMedPubMedCentralGoogle Scholar
  63. Mazefsky CA, Folstein EF, et al. Overrepresentation of mood and anxiety disorders in adults with autism and their first degree relatives: what does it mean? Autism Res. 2008;1(3):193–7.PubMedPubMedCentralGoogle Scholar
  64. McDonnell A, McCreadie M, et al. The role of physiological arousal in the management of challenging behaviors in individuals with autism spectrum disorders. Res Dev Disabil. 2015;36:311–22.Google Scholar
  65. Miodovnik A, Harstad E, et al. Timing of diagnosis of attention deficit hyperactivity disorder and autism spectrum disorder. Pediatrics. 2015;136(4):e830–7.PubMedGoogle Scholar
  66. Molloy CA, Morrow AL, et al. Familial autoimmune thyroid disease as a risk factor for regression in children with autism spectrum disorder: a CPEA study. J Autism Dev Disord. 2006;36(3):317–24.PubMedGoogle Scholar
  67. Murray MJ. Attention deficit hyperactivity disorder in the context of autism spectrum disorders. Curr Psychiatry Rep. 2010;12(5):382–8.PubMedGoogle Scholar
  68. O’Mahony SM, Stilling RM, et al. The microbiome and childhood diseases: focus on brain-gut axis. Birth Defects Res C Embryo Today. 2015;105(4):296–313.Google Scholar
  69. Packer A. Neocortical neurogenesis and the etiology of autism spectrum disorder. Neurosci Biobehav Rev. 2016;64(2016):185–95.PubMedGoogle Scholar
  70. Paquet A, Olliac B, et al. Current knowledge of motor disorders in children with Autism Spectrum Disorders. Child Neuropsychol. 2015;29:1–32.Google Scholar
  71. Parmeggiani A, Barcia G. Epilepsy and EEG paroxysmal abnormalities in autism spectrum disorder. Brain and Development. 2010;32(9):783–9.PubMedGoogle Scholar
  72. Pasterski V, Gilligan L, et al. Traits of autism spectrum disorders in adults with gender dysphoria. Arch Sex Behav. 2014;43:387–93.PubMedGoogle Scholar
  73. Peters-Scheffer N, Didden R, Korzilius H, et al. A meta-analytic study on the effectiveness of comprehensive ABA-based early intervention programs for children with autism spectrum disorders. Res Autism Spectr Disord. 2011;5:60–9.Google Scholar
  74. Pierce K, et al. Eye tracking reveals abnormal visual preference for geometric images as an early biomarker of an autism spectrum disorder subtype associated with increased symptom severity. Biol Psychiatry. 2016;79(8):657–66.PubMedGoogle Scholar
  75. Politte LC, Howe Y, et al. Evidence based treatments for autism spectrum disorder. Curr Treat Options Psychiatry. 2015;2:38–56.Google Scholar
  76. Pressler RM, Robinson RO, et al. Treatment of interictal epileptiform discharges can improve behaviour in children with behavioural problems and epilepsy. J Pediatr. 2005;146(1):112–7.PubMedGoogle Scholar
  77. Pringsheim T, Paniagiatopoulos C, Davidson J, et al. Evidence-based recommendations for monitoring safety of second-generation antipsychotics in children and youth. Pediatr Child Health. 2011;16(9):581–9. http://camesaguideline.org/.Google Scholar
  78. Reichow B, Barton EE, Boyd BA, et al. Early intensive behavioral intervention (EIBI) for young children with autism spectrum disorders (ASD). Cochrane Database Syst Rev. 2012;10:CD009260.PubMedGoogle Scholar
  79. Reichow B, Volkmar FR, et al. Systematic review and meta-analysis of pharmacological treatments of the symptoms of attention deficit/hyperactivity disorder in children with pervasive developmental disorders. J Autism Dev Disord. 2013;43(10):2435–41.PubMedPubMedCentralGoogle Scholar
  80. Rice CE, Rosanoff M, Dawson G, Durkin MS, Croen LA, Singer A, Yeargin Allsopp M. Evaluating changes in the prevalence of the autism spectrum disorders (ASDs). Public Health Rev. 2012;34(2):1–22.PubMedPubMedCentralGoogle Scholar
  81. Richard EF. Prevalence, significance of clinical characteristics of seizures, epilepsy and subclinical electrical activity in autism. NAJ Med Sci. 2015;8(3):113–22.Google Scholar
  82. Rk Y, Thiruvahindrapuram B, et al. Whole genome sequencing of quartet families with autism spectrum disorder. Nat Med. 2015;21(2):185–91.Google Scholar
  83. Robins DL, Casagrande K, et al. Validation off the modified checklist for autism in toddlers, revised with follow-up (M-CHAT-R/F). Pediatrics. 2014;133:37–45.PubMedPubMedCentralGoogle Scholar
  84. Rosenfeld CS. Microbiome disturbances and autism spectrum disorders. Drug Metab Dispos. 2015;43(10):1557–71.PubMedGoogle Scholar
  85. Rutter M, Barley A. 2003. Social communication questionnaire. www.wpspublish.com
  86. Sandin S, Lichtenstein P, et al. The familial risk of autism. JAMA. 2014;311(17):1770–7.PubMedPubMedCentralGoogle Scholar
  87. Sandin S, Schendel D, et al. Autism risk associated with parental age and with increasing difference in age between the parents. Mol Psychiatry. 2016;21(5):693–700.PubMedGoogle Scholar
  88. Schaefer GB. Clinical genetic aspects of ASD spectrum disorders. Int J Mol Sci. 2016;17(180):1–14.Google Scholar
  89. Schaefer GB, Mendelsohn NJ, et al. Clinical genetics evaluation in identifying the etiology of autism spectrum disorders: 2013 guideline revision. Genet Med. 2013;15(5):399–407.PubMedGoogle Scholar
  90. Schalkwyk V, et al. Gender identity and autism spectrum disorders. Yale J Biol Med. 2015;88:81–3.PubMedPubMedCentralGoogle Scholar
  91. Sebat J, Lakshmi B, et al. Strong association of de novo copy number mutations with autism. Science. 2007;316(5823):445–9.PubMedPubMedCentralGoogle Scholar
  92. Skagerberg D, Di Ceglie E, et al. Brief report: autistic features in children & adolescents with gender dysphoria. J Autism Dev Disord. 2015;45(8):2628–32.PubMedGoogle Scholar
  93. Smith I, Reichow B, Volkmar FR. The effects of DSM 5 criteria on number of individuals diagnosed with autism spectrum disorder: a systematic review. J Autism Dev Disord. 2015;45(8):2541–52.PubMedGoogle Scholar
  94. Sweeten TL, Bowyer SL, et al. Increased prevalence of familial autoimmunity in probands with pervasive developmental disorders. Pediatrics. 2003;112(5):e420–4.PubMedGoogle Scholar
  95. Talge NM, Neal C, et al. Antenatal maternal stress and long-term effects of child development: how and why? J Child Psychol Psychiatry. 2007;48(3–4):245–61.PubMedGoogle Scholar
  96. Tammimies K, Marshall CR, Walker S, Kaur G, Thiruvahindrapuram B, Lionel AC, Yuen RKC, Uddin M, Roberts W, Weksberg R, Woodbury-Smith M, Zwaigenbaum L, Anagnostou E, Wang Z, Wei J, Howe JL, Gazzellone MJ, Lau L, Sung WWL, Whitten K, Vardy C, Crosbie V, Tsang B, D’Abate L, Tong WWL, Luscombe S, Doyle T, Carter MT, Szatmari P, Stuckless S, Merico D, Stavropoulos DJ, Scherer SW, Fernandez BA. Molecular diagnostic yield of chromosomal microarray analysis and whole-exome sequencing in children with autism spectrum disorder. JAMA. 2015;314(9):895.PubMedGoogle Scholar
  97. Taylor B, Miller E, et al. Autism and measles, mumps, and rubella vaccine: no epidemiological evidence for a causal association. Lancet. 1999;353(9169):2026–9.PubMedGoogle Scholar
  98. The Autism treatment Network Autism speaks. 2017 (https://www.autismspeaks.org/family-services/tool-kits).
  99. The Morbidity and Mortality Weekly Report (2014) The Morbidity and Mortality Weekly Report (MMWR) 63(SS02):1–21. https://www.cdc.gov/mmwr/preview/mmwrhtml/ss6302a1.htm .
  100. Van der Meer JM, Oerlemans AM, et al. Are autism spectrum disorder and attention deficit hyperactivity disorder different manifestations of one overarching disorder? Cognitive and symptom evidence from a clinical and population-based sample. J Am Acad Child Adolesc Psychiatry. 2012;51(11):1160–72.PubMedGoogle Scholar
  101. Van Steensel FJ, Bogels SM, et al. Anxiety disorders in children and adolescents with autism spectrum disorders: a meta-analysis. Clin Child Fam Psychol Rev. 2011;14(3):302–17.PubMedPubMedCentralGoogle Scholar
  102. VanderLaan DP, Leef JH, et al. Autism spectrum disorder risk factors and autistic traits in gender dysphoric children. J Autism Dev Disord. 2015;45:1742–50.PubMedGoogle Scholar
  103. Varadinova M, Boyadjieva N. Epigenetic mechanisms: a possible link between autism spectrum disorders and fetal alcohol spectrum disorders. Pharmacol Res. 2015;102:71–80.PubMedGoogle Scholar
  104. Vasa RA, Mazurek MO, et al. Assessment and treatment of anxiety in youth with autism spectrum disorders. Pediatrics. 2016;137(2):S115–23.PubMedGoogle Scholar
  105. Visser JC, Rommelse NN, et al. Autism spectrum disorder and attention deficit hyperactivity disorder in early childhood: a review of unique and shared characteristics and developmental antecedents. Neurosci Biobehav Rev. 2016;65:229–63.PubMedGoogle Scholar
  106. Wakefield AJ, Murch SH, et al. Ileal-lymphoid-nodular hyperplasia, nonspecific colitis, and pervasive developmental disorder in children. Lancet. 1998;351(9103):637–41.PubMedGoogle Scholar
  107. Walder DJ, Laplante DP, et al. Prenatal maternal stress predicts autism traits in 6 ½ year old children: project ice storm. Psychiatry Res. 2014;219(2):353–60.PubMedGoogle Scholar
  108. Wetherby AM, Brosnan-Maddox S, et al. Validation of the infant toddler checklist as a broad band screener for autism spectrum disorders from 9 to 24 months of age. Autism. 2008;12(5):487–511.PubMedPubMedCentralGoogle Scholar
  109. White SW, Oswald D, Ollendick T, Scahill L. Anxiety in children and adolescents with autism spectrum disorders. Clin Psychol Rev. 2009;29(3):216–29.PubMedPubMedCentralGoogle Scholar
  110. Xiang AH, Wang X, et al. Association of maternal diabetes with autism in offspring. JAMA. 2015;313(14):1425–34.PubMedGoogle Scholar
  111. Zablotsky B, Black LI, et al. Estimated prevalence of autism and other developmental disabilities following questionnaire changes in the 2014 national health interview survey. Natl Health Stat Rep. 2015;87:1–20.Google Scholar
  112. Zwaigenbaum L, Bryson SE, et al. Sex differences in children with autism spectrum disorder identified within a high-risk infant cohort. J Autism Dev Disord. 2012;42:2585–96.PubMedGoogle Scholar
  113. Zwaigenbaum L, Bauman ML, et al. Early intervention for children with autism spectrum disorder under 3 years of age: recommendations for practice and research. Pediatrics. 2015;136:S60–81.PubMedGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Authors and Affiliations

  1. 1.KidsInclusive Centre for Child and Youth DevelopmentHotel Dieu HospitalKingstonCanada

Personalised recommendations